DOCK10 emerges as key trigger of dangerous insulin hypersecretion in rare pancreatic tumors

byInstitute of Science TokyoThe dedicator of cytokinesis 10 (DOCK10) gene has been identified as a key driver of abnormal insulin secretion in insulinomas, as reported by researchers from Institute of

Updated on: April 16,2026

DOCK10 emerges as key trigger of dangerous insulin hypersecretion in rare pancreatic tumors

byInstitute of Science TokyoThe dedicator of cytokinesis 10 (DOCK10) gene has been identified as a key driver of abnormal insulin secretion in insulinomas, as reported by researchers from Institute of

Updated on:April 16,2026

3 million-cell map shows menopause reshapes breast tissue, possibly raising cancer risk

byUniversity of CambridgeCredit: RDNE Stock project from PexelsScientists have created the most detailed map to date, comprised of over 3 million cells, showing how breast tissue changes as women age—

Updated on: April 11,2026

3 million-cell map shows menopause reshapes breast tissue, possibly raising cancer risk

byUniversity of CambridgeCredit: RDNE Stock project from PexelsScientists have created the most detailed map to date, comprised of over 3 million cells, showing how breast tissue changes as women age—

Updated on:April 11,2026

Study of 11,000 tumors maps 134 DNA damage signatures across 16 cancers

byUniversity of ManchesterRelationship between SBS, DBS, ID, CN and SV signatures across cancers. Credit:Nature Genetics(2026). DOI: 10.1038/s41588-025-02474-xA team of cancer genomics scientists from

Updated on: April 09,2026

Study of 11,000 tumors maps 134 DNA damage signatures across 16 cancers

byUniversity of ManchesterRelationship between SBS, DBS, ID, CN and SV signatures across cancers. Credit:Nature Genetics(2026). DOI: 10.1038/s41588-025-02474-xA team of cancer genomics scientists from

Updated on:April 09,2026

WISDOM trial weighs risk-based cancer screening

byJustin Jackson, Medical XpressVisual abstract. Credit:JAMA(2025). DOI: 10.1001/jama.2025.24784University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based

Updated on: April 07,2026

WISDOM trial weighs risk-based cancer screening

byJustin Jackson, Medical XpressVisual abstract. Credit:JAMA(2025). DOI: 10.1001/jama.2025.24784University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based

Updated on:April 07,2026

Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

by Darien Sutton,The Wistar InstituteMutant p53 interacts with ERα in ovarian cancer. Credit:Genes & Development(2025). DOI: 10.1101/gad.352953.125Scientists at The Wistar Institute have solved a

Updated on: April 07,2026

Why anti-estrogen therapy fails in ovarian cancer, and how to make it work

by Darien Sutton,The Wistar InstituteMutant p53 interacts with ERα in ovarian cancer. Credit:Genes & Development(2025). DOI: 10.1101/gad.352953.125Scientists at The Wistar Institute have solved a

Updated on:April 07,2026

Ultrasound paired with vibrating nanoparticles softens tumor tissue, improving drug delivery

byUniversity of Colorado at BoulderA microscopic image of the researchers' sound-responsive particles. Credit: Andrew Goodwin/University of Colorado BoulderCancer is one of the leading causes of d

Updated on: April 06,2026

Ultrasound paired with vibrating nanoparticles softens tumor tissue, improving drug delivery

byUniversity of Colorado at BoulderA microscopic image of the researchers' sound-responsive particles. Credit: Andrew Goodwin/University of Colorado BoulderCancer is one of the leading causes of d

Updated on:April 06,2026

Transforming cancer treatment with ultrasound

by Dan Bernardi,Syracuse UniversityCredit:Chemical Science(2025). DOI: 10.1039/d5sc05710hChemotherapy has long been a cornerstone of cancer treatment, but its effectiveness comes at a cost. The powerf

Updated on: April 05,2026

Transforming cancer treatment with ultrasound

by Dan Bernardi,Syracuse UniversityCredit:Chemical Science(2025). DOI: 10.1039/d5sc05710hChemotherapy has long been a cornerstone of cancer treatment, but its effectiveness comes at a cost. The powerf

Updated on:April 05,2026

Ultrasensitive liquid biopsy affective in predicting and monitoring immunotherapy response, study shows

byVall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPublishedtoday inClinical Cancer Research, findings from a study led by investigators at the Vall d'Hebron Institute of O

Updated on: April 05,2026

Ultrasensitive liquid biopsy affective in predicting and monitoring immunotherapy response, study shows

byVall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPublishedtoday inClinical Cancer Research, findings from a study led by investigators at the Vall d'Hebron Institute of O

Updated on:April 05,2026

Thick melanoma tumors may be linked to poorer survival than some metastatic cases

byUniversity of GothenburgCredit: Unsplash/CC0 Public DomainThe current melanoma staging system does not always reflect actual survival outcomes. In some cases, patients with thick but localized tumor

Updated on: April 04,2026

Thick melanoma tumors may be linked to poorer survival than some metastatic cases

byUniversity of GothenburgCredit: Unsplash/CC0 Public DomainThe current melanoma staging system does not always reflect actual survival outcomes. In some cases, patients with thick but localized tumor

Updated on:April 04,2026

Tracking RNA levels reveals new clues in triple-negative breast cancer progression

by Jen A. Miller,Cold Spring Harbor LaboratoryMetastatic lesions had far higher levels ofMALAT1(pink) than the surrounding tissues. Credit: Spector lab/CSHLWhen researchers look for potential cancer t

Updated on: April 04,2026

Tracking RNA levels reveals new clues in triple-negative breast cancer progression

by Jen A. Miller,Cold Spring Harbor LaboratoryMetastatic lesions had far higher levels ofMALAT1(pink) than the surrounding tissues. Credit: Spector lab/CSHLWhen researchers look for potential cancer t

Updated on:April 04,2026

T cell therapies show long-term HPV gains

by Krista Didzbalis,Rutgers UniversityCredit: Pixabay/CC0 Public DomainResearchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer

Updated on: April 03,2026

T cell therapies show long-term HPV gains

by Krista Didzbalis,Rutgers UniversityCredit: Pixabay/CC0 Public DomainResearchers from Rutgers Cancer Institute, New Jersey's only National Cancer Institute (NCI)—designated Comprehensive Cancer

Updated on:April 03,2026

Targeting B-cells may boost immunotherapy in liver cancer treatment

byHouston MethodistICB immunotherapy increased B-cell infiltration. Credit:Nature Communications(2025). DOI: 10.1038/s41467-025-66581-3Scientists have identified a promising strategy to improve liver

Updated on: April 03,2026

Targeting B-cells may boost immunotherapy in liver cancer treatment

byHouston MethodistICB immunotherapy increased B-cell infiltration. Credit:Nature Communications(2025). DOI: 10.1038/s41467-025-66581-3Scientists have identified a promising strategy to improve liver

Updated on:April 03,2026